{"id":2816,"date":"2026-06-17T09:39:16","date_gmt":"2026-06-17T13:39:16","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/cancercenter\/?page_id=2816"},"modified":"2026-06-17T14:39:07","modified_gmt":"2026-06-17T18:39:07","slug":"photonics-center","status":"publish","type":"page","link":"https:\/\/www.bumc.bu.edu\/cancercenter\/photonics-center\/","title":{"rendered":"Biomedical Engineering"},"content":{"rendered":"<h2><strong>Featured Research Project<\/strong><\/h2>\n<section class=\"featured-research\">\n<article class=\"research-card\">\n<h3><strong>&#8220;Using Light Emission to Predict How Well Breast Tumor Tissue Responds to Standard Chemotherapy&#8221;<\/strong><\/h3>\n<h4 class=\"researcher\"><strong>Darren Roblyer, PhD<\/strong><\/h4>\n<p class=\"description\">Dr. Darren Roblyer, a professor in Boston University&#8217;s College of Engineering, is bringing innovative technological solutions to the problem of determining if cancer chemotherapy is effective for tumors such as breast cancer. He has developed a wearable optical device that uses near-infrared light to determine whether tissue is reacting to cytotoxic chemotherapy, in technology similar to the pulse oximeter that we all know for measurement of blood oxygenation in a fingertip.<\/p>\n<p><a href=\"https:\/\/www.cancer.org\/research\/acs-research-news\/new-device-aims-to-use-light-to-predict-how-well-chemotherapy-treats-breast-cancer.html\">Read the Article<\/a><\/p>\n<div class=\"research-links\">\n<h3><strong>Websites<\/strong><\/h3>\n<p><a href=\"https:\/\/profiles.bu.edu\/Darren.Roblyer\">BU Profile<\/a><br \/>\n<a href=\"https:\/\/www.bu.edu\/eng\/profile\/darren-roblyer-ph-d\/\">BU College of Engineering\u00a0<\/a><br \/>\n<a href=\"https:\/\/www.bu.edu\/photonics\/profile\/darren-roblyer\/\">Photonics Center<\/a><br \/>\n<a href=\"https:\/\/www.bu.edu\/botlab\/\">Biomedical Optical Technologies Lab<\/a><br \/>\n<a href=\"https:\/\/www.researchgate.net\/profile\/Darren-Roblyer\">ResearchGate<\/a><\/p>\n<\/div>\n<\/article>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Featured Research Project &#8220;Using Light Emission to Predict How Well Breast Tumor Tissue Responds to Standard Chemotherapy&#8221; Darren Roblyer, PhD Dr. Darren Roblyer, a professor in Boston University&#8217;s College of Engineering, is bringing innovative technological solutions to the problem of determining if cancer chemotherapy is effective for tumors such as breast cancer. He has developed [&hellip;]<\/p>\n","protected":false},"author":10364,"featured_media":0,"parent":0,"menu_order":10,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/cancercenter\/wp-json\/wp\/v2\/pages\/2816"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/cancercenter\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/cancercenter\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/cancercenter\/wp-json\/wp\/v2\/users\/10364"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/cancercenter\/wp-json\/wp\/v2\/comments?post=2816"}],"version-history":[{"count":13,"href":"https:\/\/www.bumc.bu.edu\/cancercenter\/wp-json\/wp\/v2\/pages\/2816\/revisions"}],"predecessor-version":[{"id":2903,"href":"https:\/\/www.bumc.bu.edu\/cancercenter\/wp-json\/wp\/v2\/pages\/2816\/revisions\/2903"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/cancercenter\/wp-json\/wp\/v2\/media?parent=2816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}